The cure rate for moderate weak spermatozoa is uncertain, and there is no authoritative clinical information on the treatment rate for weak spermatozoa. With treatment, the patient’s fertility can be improved and assisted reproductive technology can be used if necessary.
Weak spermatozoa, also known as low sperm motility, is a condition in which less than 32% of spermatozoa move forward in the semen parameters.
Weak spermatozoa can be caused by a variety of factors, such as genetic factors, endocrine abnormalities, infectious factors, immune factors, micronutrient deficiencies and other factors, all of which can reduce sperm motility, resulting in weak spermatozoa. Patients usually have no obvious symptoms, mainly manifested as infertility.
For the treatment of weak spermatozoa. First of all, the cause of the disease should be clearly defined, and the cause of the targeted treatment, such as reproductive system infection, according to the results of the pathogen examination, the selection of sensitive antimicrobial drugs (such as levofloxacin); if there is a varicocele can be surgical treatment, and, if necessary, can be used in assisted reproduction technology to help fertilization.
Generally through timely and regular treatment, most patients can realize fertility. If there is weak spermatozoa, it should be actively treated.